• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Host Epigenetic Controls and Immune Responses Regulate Human Adenovirus Latency

by
November 15, 2026
in Biology
Reading Time: 3 mins read
0
Host Epigenetic Controls and Immune Responses Regulate Human Adenovirus Latency

Host Epigenetic Controls and Immune Responses Regulate Human Adenovirus Latency

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Human adenoviruses can establish lifelong persistence in the human body through a transcriptionally restricted state located predominantly within lymphoid tissues such as tonsils and adenoids, according to a scientific review published in Virology Journal. This persistent viral carrier state represents a significant clinical risk for reactivation-associated disease, particularly in immunocompromised hosts who lack sufficient immune defenses to prevent viral resurgence. In their publication, the authors focus specifically on examining the molecular and immunological mechanisms that govern adenovirus latency and reactivation during natural infection. Importantly, the review draws a clear distinction between the physiological regulation of natural viral persistence and the therapeutic applications of engineered adenovirus vectors commonly used in gene delivery and vaccination platforms.

According to the published evidence, adenovirus latency appears to be maintained through host-driven epigenetic regulation, which collectively suppresses viral gene expression while permitting long-term genome retention. The review highlights that host cellular machinery enforces this transcriptional silencing through multiple coordinated epigenetic mechanisms, specifically including chromatin remodeling, histone modifications, and DNA methylation. Rather than permitting active viral transcription or replication, these host-directed epigenetic constraints silence the viral genome and maintain it in a dormant state within host cells over extended periods.

However, these host-imposed epigenetic constraints are not permanent and can be disrupted by various physiological triggers and pharmacological agents, thereby promoting viral reactivation. The review notes that cellular exposure to oxidative stress, inflammatory signaling pathways, and general immune suppression can weaken or destabilize the epigenetic constraints that keep the virus dormant. Furthermore, therapeutic compounds such as histone deacetylase inhibitors have been shown to directly disrupt these repressive chromatin structures and promote viral reactivation. When these regulatory barriers are compromised, the virus escapes transcriptional silencing, leading to renewed viral gene expression and initiating the transition toward active viral replication.

Alongside epigenetic regulation, effective host immune surveillance plays a pivotal role in restraining latent adenovirus and preventing the development of severe disease. Specifically, virus-specific T-cell responses appear to play an essential role in keeping the dormant pathogen under control within lymphoid tissues. When a host maintains robust cellular immunity, these virus-specific T cells continuously restrain the latent viral reservoir. Conversely, impairment of host immunity significantly increases susceptibility to viral reactivation, enabling the previously dormant adenovirus to overcome immunological constraints, resume replication, and potentially cause disseminated disease across vulnerable patient populations.

Finally, the review summarizes recent scientific advances in understanding the epigenetic and immunometabolic regulation of adenovirus latency and evaluates potential therapeutic strategies aimed at controlling viral reactivation. These proposed approaches include antiviral agents that target actively replicating virus during reactivation events, epigenetic modulators designed to stabilize transcriptional silencing and preserve viral latency, and immunotherapeutic strategies aimed at restoring adenovirus-specific immunity. Crucially, the authors emphasize that evaluating antiviral interventions against natural adenovirus reactivation requires distinct therapeutic strategies compared to the use of engineered, replication-deficient adenoviral vectors employed for gene delivery and vaccination.

Subject of Research: Epigenetic and immunological regulation of human adenovirus latency and reactivation

Article Title: Physiological regulation of adenovirus latency: epigenetic control, immune-mediated reactivation and therapeutic opportunities

Article References: Wang, L., Qin, K., Chen, C., Ren, S., Arain, M. A., Li, T., Cao, L., & Wang, S. (2026). Physiological regulation of adenovirus latency: epigenetic control, immune-mediated reactivation and therapeutic opportunities. Virology Journal. https://doi.org/10.1186/s12985-026-03361-5

Image Credits: AI Generated

DOI: 10.1186/s12985-026-03361-5

Keywords: human adenoviruses, adenovirus latency, viral persistence, lymphoid tissues, tonsils, adenoids, immunocompromised hosts, epigenetic regulation, chromatin remodeling, histone modifications, DNA methylation, viral reactivation, oxidative stress, inflammatory signaling, histone deacetylase inhibitors, immune surveillance, virus-specific T-cells, immunometabolic regulation

News Source: Juliet Wilcox. (November 15, 2026). Host Epigenetic Controls and Immune Responses Regulate Human Adenovirus Latency. Scienmag.

Tags: adenoidsadenovirus latencychromatin remodelingDNA Methylationepigenetic regulationhistone deacetylase inhibitorshistone modificationshuman adenovirusesimmune surveillanceimmunocompromised hostsimmunometabolic regulationinflammatory signalinglymphoid tissuesoxidative stresstonsilsviral persistenceviral reactivationvirus-specific T-cells
Share12Tweet7Share2ShareShareShare1

Related Posts

Machine Learning Identifies Environmental Triggers of Fumonisin Outbreaks in Texas Corn

Machine Learning Identifies Environmental Triggers of Fumonisin Outbreaks in Texas Corn

November 16, 2026
Study Uncovers Sex-Specific Gut Microbiome Changes in Alzheimer's Disease

Study Uncovers Sex-Specific Gut Microbiome Changes in Alzheimer’s Disease

November 16, 2026

Matrix Environment Directs Architecture and Lactation Programs in Human Milk Organoids

November 16, 2026

Kenyan Smallholder Farmers Classify Diverse Pasture Species for Sustainable Dairy Production

November 16, 2026

POPULAR NEWS

  • Maintenance BCG Reduces Bladder Cancer Progression When Patients Overcome Treatment Barriers

    Maintenance BCG Reduces Bladder Cancer Progression When Patients Overcome Treatment Barriers

    29 shares
    Share 12 Tweet 7
  • High-Avidity BCMA CAR T-Cell Therapy Shows High Efficacy in AL Amyloidosis

    29 shares
    Share 12 Tweet 7
  • Zero Mass Limit in Karch-Randall Gravity Yields Decoupled Massive Vector Theory

    29 shares
    Share 12 Tweet 7
  • Kenyan Smallholder Farmers Classify Diverse Pasture Species for Sustainable Dairy Production

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Rare Lung Tumor Case Shows Limited Response to Apatinib and Hormonal Therapy

Blood Tube Selection May Bias Findings in Longitudinal SCFA Research

TyG-CVAI Shows Moderate Accuracy for Identifying Prevalent Hyperuricemia Across Adult Cohorts

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.